Envoy Medical, Inc.COCHNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -30.00% | -55.79% | -22.03% | +14.71% | -25.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | -454.71% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | -481.32% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | -631.61% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | -631.61% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.34% | +8.81% | +14.66% | +9.10% | -0.08% |
| Weighted Average Shares Diluted Growth | +0.34% | +8.81% | +14.66% | -0.00% | -0.08% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -355.41% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -429.99% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -79.35% | +1068.57% | -81.00% | -68.81% | -84.72% |
| Inventory Growth | +17.47% | +21.65% | +13.88% | +0.32% | -0.12% |
| Asset Growth | -60.18% | +39.50% | +22.46% | +46.95% | -12.94% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +2550.08% | +3398.40% | +348.64% | +235.74% | -93.94% |
| R&D Expense Growth | +49.03% | -19.12% | +16.44% | -4.09% | -2.07% |
| SG&A Expenses Growth | +46.28% | -45.08% | -10.84% | +16.11% | +36.48% |